Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Lineage to Present at 3rd Annual H.C. Wainwright BioConnect Investor Conference at Nasdaq NYC
Lineage to Present at 3rd Annual H.C. Wainwright BioConnect Investor Conference at Nasdaq NYC


Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that Brian M

Form 8.3 - The Vanguard Group, Inc.: Dalata Hotel Group plc
Form 8.3 - The Vanguard Group, Inc.: Dalata Hotel Group plc
Form 8.3 - The Vanguard Group, Inc.: Dalata Hotel Group plc
Form 8.3 - The Vanguard Group, Inc.: Primary Health Properties plc
Form 8.3 - The Vanguard Group, Inc.: Primary Health Properties plc
Form 8.3 - The Vanguard Group, Inc.: Primary Health Properties plc
Form 8.3 - The Vanguard Group, Inc.: Assura plc
Form 8.3 - The Vanguard Group, Inc.: Assura plc
Form 8.3 - The Vanguard Group, Inc.: Assura plc
Form 8.3 - The Vanguard Group, Inc.: Greencore Group plc
Form 8.3 - The Vanguard Group, Inc.: Greencore Group plc
Form 8.3 - The Vanguard Group, Inc.: Greencore Group plc
Form 8.3 - The Vanguard Group, Inc.: Bakkavor Group plc
Form 8.3 - The Vanguard Group, Inc.: Bakkavor Group plc
Form 8.3 - The Vanguard Group, Inc.: Bakkavor Group plc
Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc
Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc
Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc
Form 8.3 - The Vanguard Group, Inc.: Aviva plc
Form 8.3 - The Vanguard Group, Inc.: Aviva plc
Form 8.3 - The Vanguard Group, Inc.: Aviva plc
Form 8.3 - The Vanguard Group, Inc.: Life Science REIT plc
Form 8.3 - The Vanguard Group, Inc.: Life Science REIT plc
Form 8.3 - The Vanguard Group, Inc.: Life Science REIT plc
Form 8.3 - The Vanguard Group, Inc.: Urban Logistics REIT plc
Form 8.3 - The Vanguard Group, Inc.: Urban Logistics REIT plc
Form 8.3 - The Vanguard Group, Inc.: Urban Logistics REIT plc
EQS-News: Invitation to the Annual General Meeting of MLP SE published
EQS-News: Invitation to the Annual General Meeting of MLP SE published
EQS-News: Invitation to the Annual General Meeting of MLP SE published
Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc
Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc
Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc
Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Form 8.3 - The Vanguard Group, Inc.: Dowlais Group plc
Form 8.3 - The Vanguard Group, Inc.: Dowlais Group plc
Form 8.3 - The Vanguard Group, Inc.: Dowlais Group plc
Form 8.3 - The Vanguard Group, Inc.: PRS REIT plc
Form 8.3 - The Vanguard Group, Inc.: PRS REIT plc
Form 8.3 - The Vanguard Group, Inc.: PRS REIT plc
Results of Annual Shareholders Meeting of R&S Group Holding AG
Results of Annual Shareholders Meeting of R&S Group Holding AG
Results of Annual Shareholders Meeting of R&S Group Holding AG
Form 8.3 - The Vanguard Group, Inc.: Deliveroo plc
Form 8.3 - The Vanguard Group, Inc.: Deliveroo plc
Form 8.3 - The Vanguard Group, Inc.: Deliveroo plc
CI Financial Reports Financial Results for the First Quarter of 2025
CI Financial Reports Financial Results for the First Quarter of 2025


CI Financial Corp. (“CI”) (TSX: CIX) today released financial results for the quarter ended March 31, 2025.



Financial highlights



First quarter net loss attributable to shareholders was $8.5

Scholar Rock Reports First Quarter 2025 Financial Results and Highlights Business Progress
Scholar Rock Reports First Quarter 2025 Financial Results and Highlights Business Progress


Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on developing and commercializing apitegromab for patients with spinal muscular atrophy (SMA) and other severe and

Block Listing Six Monthly Return
Block Listing Six Monthly Return
Block Listing Six Monthly Return
Pembina Pipeline Corporation Announces Renewal of Share Repurchase Program
Pembina Pipeline Corporation Announces Renewal of Share Repurchase Program


Pembina Pipeline Corporation ("Pembina" or the "Company") (TSX: PPL; NYSE: PBA) announced today that the Toronto Stock Exchange (the "TSX") has approved the renewal of Pembina's normal course

Kforce Inc. Announces Participation in R.W. Baird’s 2025 Global Consumer, Technology & Services Conference
Kforce Inc. Announces Participation in R.W. Baird’s 2025 Global Consumer, Technology & Services Conference


Kforce Inc. (NYSE: KFRC), a provider of professional staffing services and solutions, announced today that Kforce management will present at The R.W. Baird 2025 Global Consumer, Technology &amp

Distribution Solutions Group to Participate in the 25th Annual KBCM Industrials & Basic Materials Conference May 28, 2025
Distribution Solutions Group to Participate in the 25th Annual KBCM Industrials & Basic Materials Conference May 28, 2025


Distribution Solutions Group, Inc. (NASDAQ: DSGR) (“DSG” or the “Company"), a premier specialty distribution company, today announced that management will participate in one-on-one investor

Monro, Inc. to Report Fourth Quarter and Year-End Fiscal 2025 Earnings on May 28, 2025
Monro, Inc. to Report Fourth Quarter and Year-End Fiscal 2025 Earnings on May 28, 2025


Monro, Inc. (Nasdaq: MNRO), a leading provider of automotive undercar repair and tire services, will release its fiscal 2025 fourth quarter and year-end earnings on May 28, 2025. The Company will

Travis Perkins: Results of AGM
Travis Perkins: Results of AGM
Travis Perkins: Results of AGM